|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1994-5-25
|
|
pubmed:abstractText |
Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
151
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
756-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8166320-Adult,
pubmed-meshheading:8166320-Behavior Therapy,
pubmed-meshheading:8166320-Combined Modality Therapy,
pubmed-meshheading:8166320-Dose-Response Relationship, Drug,
pubmed-meshheading:8166320-Drug Administration Schedule,
pubmed-meshheading:8166320-Female,
pubmed-meshheading:8166320-Haloperidol,
pubmed-meshheading:8166320-Hospitalization,
pubmed-meshheading:8166320-Humans,
pubmed-meshheading:8166320-Interpersonal Relations,
pubmed-meshheading:8166320-Male,
pubmed-meshheading:8166320-Schizophrenia,
pubmed-meshheading:8166320-Schizophrenic Psychology,
pubmed-meshheading:8166320-Self Care
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Optimal drug and behavior therapy for treatment-refractory schizophrenic patients.
|
|
pubmed:affiliation |
Camarillo-UCLA Research Center, Camarillo State Hospital, CA 93011-6022.
|
|
pubmed:publicationType |
Journal Article
|
